These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3114506)

  • 1. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective.
    Maki DG; Botticelli JT; LeRoy ML; Thielke TS
    JAMA; 1987 Oct; 258(13):1777-81. PubMed ID: 3114506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy.
    Matlow AG; Kitai I; Kirpalani H; Chapman NH; Corey M; Perlman M; Pencharz P; Jewell S; Phillips-Gordon C; Summerbell R; Ford-Jones EL
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):487-93. PubMed ID: 10432161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?
    Raad I; Hanna HA; Awad A; Alrahwan A; Bivins C; Khan A; Richardson D; Umphrey JL; Whimbey E; Mansour G
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):136-9. PubMed ID: 11310690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-line filters in central venous catheters in a neonatal intensive care unit.
    van den Hoogen A; Krediet TG; Uiterwaal CS; Bolenius JF; Gerards LJ; Fleer A
    J Perinat Med; 2006; 34(1):71-4. PubMed ID: 16489888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing for intravenous administration set replacement.
    Gillies D; O'Riordan L; Wallen M; Morrison A; Rankin K; Nagy S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003588. PubMed ID: 16235329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of changing intravenous delivery systems at longer than 24-hour intervals.
    Band JD; Maki DG
    Ann Intern Med; 1979 Aug; 91(2):173-8. PubMed ID: 111593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total parenteral nutrition: a study of the microbial contamination of the bags and the infusion lines].
    Pacifici A; Manieri R; De' Medici M
    Ann Ital Chir; 1992; 63(1):89-91; discussion 91-2. PubMed ID: 1605452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 24-hour intravenous tubing set change on the sterility of repackaged fat emulsion in neonates.
    Reiter PD; Robles J; Dowell EB
    Ann Pharmacother; 2004 Oct; 38(10):1603-7. PubMed ID: 15328398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy.
    Danzig LE; Short LJ; Collins K; Mahoney M; Sepe S; Bland L; Jarvis WR
    JAMA; 1995 Jun; 273(23):1862-4. PubMed ID: 7776503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine changing of intravenous administration sets does not reduce colonization or infection in central venous catheters.
    Rickard CM; Lipman J; Courtney M; Siversen R; Daley P
    Infect Control Hosp Epidemiol; 2004 Aug; 25(8):650-5. PubMed ID: 15357156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous tubing with burettes can be safely changed at 48-hour intervals.
    Gorbea HF; Snydman DR; Delaney A; Stockman J; Martin WJ
    JAMA; 1984 Apr; 251(16):2112-5. PubMed ID: 6708261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endemic rate of fluid contamination and related septicemia in arterial pressure monitoring.
    Maki DG; Hassemer CA
    Am J Med; 1981 Mar; 70(3):733-8. PubMed ID: 7211907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of intravenous administration set changes: a systematic review.
    Gillies D; O'Riordan L; Wallen M; Rankin K; Morrison A; Nagy S
    Infect Control Hosp Epidemiol; 2004 Mar; 25(3):240-50. PubMed ID: 15061417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microfilters within the scope of infusion therapy--possibilities and problems in retention of microbial and particle contaminants].
    Bach A; Böttiger BW
    Zentralbl Chir; 1994; 119(4):268-75. PubMed ID: 8203178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endemic nosocomial gram-negative bacteraemias resulting from contamination of intravenous heparin infusions.
    Playford EG; Looke DF; Whitby M; Stackelroth J; Harrison K; Watts A
    J Hosp Infect; 1999 May; 42(1):21-6. PubMed ID: 10363207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric primary gram-negative nosocomial bacteremia: a possible relationship with infusate contamination.
    Macías-Hernández AE; Hernández-Ramos I; Muñoz-Barrett JM; Vargas-Salado E; Guerrero-Martínez FJ; Medina-Valdovinos H; Hernández-Hernández J; Ponce-de-León-Rosales S
    Infect Control Hosp Epidemiol; 1996 May; 17(5):276-80. PubMed ID: 8727615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with the multiple lumen central venous catheter.
    Kaufman JL; Rodriguez JL; McFadden JA; Brolin RE
    JPEN J Parenter Enteral Nutr; 1986; 10(5):487-9. PubMed ID: 3093705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contamination of intravenous infusion systems--the effect of changing administration sets.
    Jakobsen CJ; Grabe N; Nielsen E; Højbjerg T; Damm M; Lorentzen K; Ersgaard HV; Villadsen J; Heebøl-Holm B; Madsen JI
    J Hosp Infect; 1986 Nov; 8(3):217-23. PubMed ID: 2878025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications of intravenous therapy. Influence of parenteral nutrition, central venous pressure and antibiotics].
    Armero M; Henríquez MT; Oyamburu B; Eleta AM; Ballesteros A; Revuelta J
    Nutr Hosp; 1991; 6(3):186-93. PubMed ID: 8620051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin A sorption to polyvinyl and polyolefin intravenous tubing.
    Henton DH; Merritt RJ
    JPEN J Parenter Enteral Nutr; 1990; 14(1):79-81. PubMed ID: 2109120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.